Stevanato Group’s Expansion

Stevanato Group announced in June 2021 their intent to build a 200,000-square foot facility in the Fishers Life Science and Innovation Park with a $140 million investment to build their facility and hire 250 employees for their high-wage, innovation positions. In early 2022, Stevanato executives approached the City of Fishers to share their plans to further invest in their planned facility. Stevanato will present a proposal to the Fishers City Council to update its total investment to $512 million with a plan to hire a total of 515 employees by 2031. The Stevanato facility will open in early 2024.

“Stevanato’s additional commitment to Fishers is incredibly encouraging for the market, this sector, and reaffirming Fishers’ position as a destination for life science firms,” said Mayor Fadness. “By more than doubling their investment in Fishers, Stevanato’s position as a global leader will undoubtedly positively impact our community and regional neighbors.”

For more information about this announcement, visit thisisFishers.com/NextChapter.

###

About Stevanato Group
Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients. To learn more, visit stevanatogroup.com.